No products in the cart.
New Breast Cancer Rx to Be Given at Home
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication that can be given at home. This new medication is found under the
Leave a comment
New Breast Cancer Rx Approved
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication. This new approval is called Trodelvy (sacituzumab govitecan-hziy). The FDA approved it to
New Breast Cancer Rx Gets Go-Ahead
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication. This new approval is called Tukysa (tucatinib). The FDA approved it to treat
Breast Cancer Rx Gets New Indication
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new indication for a breast cancer drug. The medication is Nerlynx (neratinib). It is now approved to
New Breast Cancer Rx Gets Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat breast cancer. This new approval is called Enhertu (fam-trastuzumab deruxtecan-nxki). The FDA approved
Mammograms: What You Need to Know
[ad_1] (RxWiki News) Mammograms can help detect breast cancer at an early stage. That means they can lead to early treatment, which can save lives. Early breast cancer treatment can
Mammogram Myths | RxWiki
[ad_1] (RxWiki News) For Breast Cancer Awareness Month, we’re debunking four common mammogram myths. Mammograms are low-dose X-ray pictures of the breast. Because mammography can detect breast cancer tumors before
Another Biosimilar to Herceptin | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar to a drug that treats breast, stomach and esophageal cancer. This biosimilar is called Kanjinti (trastuzumab-anns).
Breast Cancer Rx Now Approved for Men
[ad_1] (RxWiki News) A breast cancer medication that was previously approved for women can now be used to treat men with advanced breast cancer. This medication is called Ibrance (palbociclib).
Another Biosimilar for a Common Breast Cancer Rx
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar for a common breast cancer medication. The FDA recently approved Trazimera (trastuzumab-qyyp) to treat breast cancer.